JPJosué Pereira

Josué Pereira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josué Pereira has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pediatric Embryonal Tumor With Multilayered Rosettes (ETMR): Retrospective Single-Center Case Series of 4 Patients

    by João Meira Gonçalves, Jorge Pinheiro, Susana Nunes, Ana P. Fernandes, Daniela Alves, Luísa Sampaio, Lígia Osório, Jorge Lima, Josué Pereira, Maria João Gil-Da-Costa

    Background: Embryonal tumor with multilayered rosettes (ETMR) is a rare, aggressive pediatric tumor whose diagnosis now relies on integrated molecular criteria. Observations: Between 2015 and 2025, we treated 4 children (18 mo to 5 y). The first diagnosis was based on morphology and LIN28A immunoreactivity, the second on C19MC amplification, and the last 2 on methylation profiling after weak or absent LIN28A. All received multimodal therapy. One died 18 months after diagnosis; 3 were alive, one beyond 10 years. Conclusions: The series documents clinicopathological heterogeneity in ETMR. Molecular profiling contributed to diagnosis in cases with weak or absent LIN28A immunoreactivity.

  • Open Access

    Acromegaly with congenital generalized lipodystrophy – two rare insulin resistance conditions in one patient: a case report

    by Vanessa Guerreiro, Irene Bernardes, Josué Pereira, Roberto Pestana Silva, Susana Fernandes, Davide Carvalho, Paula Freitas

    Background: Lipodystrophies are a group of diseases which are characterized by abnormal adipose tissue deposition and are frequently associated with metabolic changes. Congenital generalized lipodystrophy is an autosomal recessive syndrome, with a prevalence < 1:10 million. Acromegaly is a rare disease, secondary to the chronic hypersecretion of growth hormone and insulin-like growth factor-1, with characteristic metabolic and somatic effects. “Acromegaloidism” is a term used for patients who manifest clinical features of acromegaly, but do not present a demonstrable hormone growth hypersecretion. The extreme shortage of subcutaneous adipose tissues and muscle hypertrophy confer an acromegaloid-like appearance in these patients. Case presentation: We describe a case of a patient with the rare combination of Berardinelli–Seip congenital lipodystrophy and acromegaly; our patient is a 63-year-old white man, who was referred to an endocrinology consultation for suspected lipodystrophy. He had lipoatrophy of upper and lower limbs, trunk, and buttocks, with muscular prominence, acromegaloid facial appearance, large extremities, and soft tissue tumescence. In addition, he had dyslipidemia and prediabetes. His fat mass ratio (% trunk fat mass/% lower limbs fat mass) was 1.02 by densitometry and he also had hepatomegaly, with mild steatosis (from an abdominal ultrasound), and left ventricular hypertrophy (from an electrocardiogram). His first oral glucose tolerance test had growth hormone nadir of 0.92 ng/mL, and the second test, 10 months afterwards, registered growth hormone nadir of 0.64 ng/mL (growth hormone nadir < 0.3 ng/mL excludes acromegaly). Pituitary magnetic resonance imaging identified an area of hypocaptation of contrast product in relation to a pituitary adenoma and he was subsequently submitted to transsphenoidal surgical resection of the mass. A pathological evaluation showed pituitary adenoma with extensive expression of growth hormone and adrenocorticotropic hormone, as well as a rare expression of follicle-stimulating hormone and prolactin. A genetic study revealed an exon 3/exon 4 deletion of the AGPAT2 gene in homozygosity. Conclusions: Congenital generalized lipodystrophy is a rare disease which occurs with acromegaloid features. As far as we know, we have described the first case of genetic lipodystrophy associated with true acromegaly. Although this is a rare association, the presence of congenital generalized lipodystrophy should not exclude the possibility of simultaneous acromegaly.


  • Open Access

    Giant prolactinoma, germline BRCA1 mutation, and depression: a case report

    by Rita Bettencourt-Silva, Joana Queirós, Josué Pereira, Davide Carvalho

    Giant prolactinomas are very rare pituitary tumors that may exhibit an aggressive behavior and present with a life-threatening condition. A 25-year-old white woman was admitted to our hospital with a headache, psychomotor retardation, reduced vision, and loss of autonomy in daily activities. Her past medical history was significant for having oligomenorrhea and a depressive syndrome since her mother’s death. She also had a breast cancer gene 1 (BRCA1) mutation and a family history of breast cancer. She had marked hyperprolactinemia (7615 ng/dL), central hypocortisolism, growth hormone deficiency, and a giant pituitary tumor (52 × 30 × 33 mm) which was shown in magnetic resonance imaging with obstructive hydrocephalus, requiring emergency surgery. Treatment with cabergoline led to a 99.8% reduction in serum prolactin levels and significant tumor shrinkage. Her depressive symptoms progressively improved and psychiatric drugs were withdrawn after 3 months of cabergoline treatment. Currently, she is being followed in Endocrinology, Neurosurgery, and Neurophthalmology out-patient clinics and in a breast cancer unit. Careful monitoring, support, and follow-up will be essential throughout this patient’s life. This case is a rare presentation of a giant prolactinoma in a young woman, who presented a life-threatening event. She also had an unexpected association between diseases or symptoms that may have contributed to the delay in diagnosis. Given the concomitant presence of a giant prolactinoma, a BRCA1 mutation, and depressive symptoms, a possible association was hypothesized. The breast cancer risk in a BRCA1 mutation carrier and the possible interference of hyperprolactinemia and life events were also discussed. However this hypothesis requires further investigation.


  • Open Access

    A challenging coexistence of central diabetes insipidus and cerebral salt wasting syndrome: a case report

    by Maria Manuel Costa, César Esteves, José Luís Castedo, Josué Pereira, Davide Carvalho

    Combined central diabetes insipidus and cerebral salt wasting syndrome is a rare clinical finding. However, when this happens, mortality is high due to delayed diagnosis and/or inadequate treatment. A 42-year-old white man was referred to neurosurgery due to a non-functional pituitary macroadenoma. He underwent a partial resection of the tumor on July 2, 2015. On the day following surgery he presented polyuria with sodium 149 mEq/L, plasma osmolality 301 mOsm/kg, and urine osmolality 293 mOsm/kg. He started nasal desmopressin 0.05 mg/day with good response. He was already on dexamethasone 4 mg and levothyroxine 75 mcg due to hypopituitarism after surgery. On July 9 he became confused. Cerebral computed tomography was performed with no significant changes. His natremia dropped to 128 mEq/L with development of polyuria despite maintenance of desmopressin dose. His hemoglobin and hematocrit rose from 9.1 g/L to 11.6 g/L and 27.5 to 32.5, respectively. His thyroid function was normal and he was on hydrocortisone 30 mg/day. At 12 p.m. 150 mg/hydrocortisone infusion was initiated, but sodium did not increase. Plasma and urine osmolality were 264 mOsm/kg and 679 mOsm/kg, respectively. At 4 p.m. hydrocortisone was increased and hypertonic saline replacement started. Two hours later he was dehydrated with polyuria and vomiting, and natremia of 124 mEq/L. Hyponatremia was very resistant to treatment despite hypertonic saline replacement, hence desmopressin was suspended. The following day, urine spot analysis showed that natriuresis was 63 mEq/L with serum sodium 132 mEq/L. This was interpreted as a cerebral salt wasting syndrome and control was achieved with aggressive hypertonic saline replacements and fludrocortisone 0.1 mg/three times a day. We present a rare case of a patient with diabetes insipidus and cerebral salt wasting syndrome, who was successfully treated. Hyponatremia in a patient with diabetes insipidus may erroneously be interpreted as inadequate diabetes insipidus control or as syndrome of inappropriate antidiuretic hormone secretion, leading to therapeutic errors. Thus, all clinical and analytical data should be evaluated together for early and correct diagnosis.


  • Endoscopic re-opening of third ventriculostomy: Case series and review of literature

    by Inês Moreira, Josué Pereira, Joana Oliveira, Sérgio F. Salvador, Rui Vaz


  • Decompressive craniectomy for massive internal carotid artery infarction after pediatric penetrating neck trauma

    by Bruno Miguel Fernandes de Carvalho, Clara Chamadoira, Rita Figueiredo, Josué Pereira, Luísa Gaspar, Rui Vaz

    Pediatric penetrating carotid arterial trauma is a rare unreported cause of malignant cerebral infarction. Despite increasing evidence of benefit of decompressive hemicraniectomy (DCH) in pediatric malignant stroke, indications and predictors of outcome remain controversial. We report a 4-year-old boy with penetrating zone II neck trauma with laceration of the right internal carotid artery who developed malignant cerebral infarction requiring DCH. Impressive neurological recovery and excellent functional outcome was observed with good psychomotor development and quality of life. To our knowledge, this is the first reported case of pediatric malignant ICA infarction due to penetrating arterial trauma with good neurologic outcome after DCH.


  • Cushing's disease caused by atypical pituitary adenoma

    by Maria Manuel Costa, Claudia Nogueira, Joana Oliveira, Filipe Cunha, Ligia Castro, Josue Pereira, Eduardo Vinha, Davide Carvalho

    Introduction: Cushing’s Disease results of corticotrophin (ACTH) hypersecretion from pituitary which increases cortisol production. WHO classified pituitary tumors as typical adenoma, atypical adenoma and carcinoma. Diagnostic criteria for an atypical adenoma include invasive growth, elevated mitotic index, Ki-67 labeling index greater than 3% and extensive p53 immunoreactivity. Case Report: Sixty-eight years-old man presented to our consult with history of visual complaints, brain MRI showing a 15 mm invasive pituitary macroadenoma and with hormonal testing revealing ACTH 100 pg/ml (9–52), urinary free cortisol (UFC) 591 μg/24 h (10–136) and hypogonadotropic hypogonadism. He repeated UFC that was positive and made a low dose dexamethasone test (LDDST) with no suppression. The results of the high dose dexamethasone test and the CRH test were not suggestive of CD. Inferior petrosal sinus sampling for ACTH was performed only on the right side with no central/peripheral gradient. Neck, chest and abdomen CT showed no significant alterations. He was submitted to transsphenoidal resection due invasive macroadenoma with compressive symptoms, including left ptosis worsening. Tumor pathology showed epithelial neoplasia type with atypia and frequent mitoses. There was diffuse ACTH staining and almost diffuse p53 expression. Ki67 labelling index was 25%. After surgery ACTH 73.6 (<63.3 pg/ml) and LDDST suppression. The patient began treatment with ketoconazole and was proposed for radiotherapy. Conclusions: Dynamic noninvasive tests were not suggestive of CD, however these tests have poor negative predictive value. Carcinoma is defined by the presence of metastases, who this patient did not reveal. This clinic case illustrates an example of a pituitary tumor with a pathological and immunohistochemical studies indicating a highly proliferative activity, aggressive growth and malignant potential, even so it is classified as atypical tumor. These tumors must have a tight follow-up for early detection of recurrence and/or metastasis.

  • Open Access

    The infratentorial supracerebellar approach in surgery of lesions of the pineal region

    by Joana Oliveira, António Cerejo, PedroSantos Silva, Patrícia Polónia, Josué Pereira, Rui Vaz

    Background: Surgery of pineal region lesions is considered a challenging task, due to the particular relationship of lesions in this location with neural and vascular structures. Few series with a significant experience of dealing with these patients have been reported. Methods: We review our experience using infratentorial supracerebellar approach in the surgery of pineal region, regarding the extension of the removal, postoperative morbidity, and discussing details of the surgical technique. In all cases, a supracerebellar infratentorial approach was used in the semi sitting position. Results: A total of 32 patients were operated in the past 20 years (3 germinomas, 3 teratoma, 3 pineocitoma, 2 pineal tumor of intermediate differentiation, 6 pineoblastomas, 6 low grade astrocytoma, 2 glioblastoma, 2 metastasis, 1 ependymoma, 1 epidermoid tumor, 1 cavernoma, and 2 arachnoid cyst). Total removal was achieved in 15 cases and subtotal extensive removal in 7 patients. In the remaining cases, only partial removal was possible, due to the involved pathological types. There was no surgical mortality and no cases of cerebellar venous infarction. Morbidity consisted of transient ocular movement disturbance in 14 patients, transient ataxia in 3 patients, and 1 case of local cerebrospinal fluid (CSF) fistula with meningitis that required surgical treatment. Conclusion: Supracerebellar infratentorial is a safe approach to lesions in the pineal region, and total or extensive subtotal removal is possible in most cases, with acceptable morbidity.